VVOS
Price:
$0.572
Market Cap:
$3.37M
Vivos Therapeutics, Inc. is a medical technology enterprise dedicated to developing and commercializing advanced treatment solutions for adults facing conditions like dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring. The company's flagship product, the Vivos System, offers a unique multi-disciplinary therapy that stands out for being non-invasive, non-surgical, and free of pharmaceuticals, specifically addressing these dentofacial and sleep-related issues. Additionally, Vivos Therapeutics provides the VivoScore Program, a service encompassing comprehensive screening and convenient home sleep tests for both adults and children. The Vivos System is distributed and sold to ...[Read more]
Industry
Medical - Devices
IPO Date
2020-12-11
Stock Exchange
NASDAQ
Ticker
VVOS
According to Vivos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -2239.18%. This represents a change of -1185.44% compared to the average of 206.29% of the last 4 quarters.
The mean historical ROE of Vivos Therapeutics, Inc. over the last ten years is -309.61%. The current -2239.18% ROE has changed 623.24% with respect to the historical average. Over the past ten years (40 quarters), VVOS's ROE was at its highest in in the March 2026 quarter at 681.11%. The ROE was at its lowest in in the September 2023 quarter at -4550.00%.
Average
-309.61%
Median
-109.72%
Minimum
-3304.87%
Maximum
1.42%
Discovering the peaks and valleys of Vivos Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 565.41%
Maximum Annual ROE = 1.42%
Minimum Annual Increase = -1117.70%
Minimum Annual ROE = -3304.87%
| Year | ROE | Change |
|---|---|---|
| 2025 | 1.42% | -1117.70% |
| 2024 | -140.01% | -95.76% |
| 2023 | -3304.87% | 565.41% |
| 2022 | -496.67% | 525.22% |
| 2021 | -79.44% | 11.46% |
| 2020 | -71.27% | -119.50% |
| 2019 | 365.41% | -309.00% |
The current ROE of Vivos Therapeutics, Inc. (VVOS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-673.35%
5-year avg
-519.23%
10-year avg
-309.61%
Vivos Therapeutics, Inc.’s ROE is less than Allurion Technologies Inc. (44.17%), greater than enVVeno Medical Corporation (-66.39%), greater than Co-Diagnostics, Inc. (-164.92%), greater than Aethlon Medical, Inc. (-137.73%), less than Envoy Medical, Inc. (239.44%), greater than Adagio Medical Holdings, Inc. (-382.50%), less than OSR Holdings, Inc. (-15.90%), greater than Adlai Nortye Ltd. (-414.01%), greater than Lipocine Inc. (-66.69%), less than American Shared Hospital Services (-6.38%),
| Company | ROE | Market cap |
|---|---|---|
| 44.17% | $4.98M | |
| -66.39% | $165.03K | |
| -164.92% | $4.79M | |
| -137.73% | $1.54M | |
| 239.44% | $13.06M | |
| -382.50% | $11.34M | |
| -15.90% | $9.36M | |
| -414.01% | $547.79M | |
| -66.69% | $13.12M | |
| -6.38% | $9.41M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vivos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vivos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Vivos Therapeutics, Inc.'s ROE?
How is the ROE calculated for Vivos Therapeutics, Inc. (VVOS)?
What is the highest ROE for Vivos Therapeutics, Inc. (VVOS)?
What is the 3-year average ROE for Vivos Therapeutics, Inc. (VVOS)?
What is the 5-year average ROE for Vivos Therapeutics, Inc. (VVOS)?
How does the current ROE for Vivos Therapeutics, Inc. (VVOS) compare to its historical average?